Cafepharma Today

AstraZeneca’s tremelimumab does not perform well in NSCLC trial
Does AstraZeneca pay its CEO too much?
The latest on Brexit and the pharma industry
Boston Scientific plans $200M restructuring
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

Biopharma Dive
Monday, November 12, 2018 - 11:30pm
Pharmaceutical Business Review
Monday, November 12, 2018 - 9:26am
CP Wire
Monday, November 12, 2018 - 9:17am

Pages

Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.